Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Differential expression and secretion of alpha 1 anti-trypsin between direct DNA injection and implantation of transfected myoblast

Abstract

Muscle can be used for systemic delivery of non-muscle proteins. In order to investigate the relative effectiveness of direct DNA plasmid injection versus implantation of genetically modified myogenic cell lines, we have used the human alpha 1 anti-trypsin (α1AT) cDNA driven by either cytomegalovirus (CMV) or the muscle creatine kinase 3.3 kb (MCK) promoter in immunodeficient mice. We dem- onstrate that the implantation of transfected myoblasts stably expressing the human α1AT cDNA generates a more persistent production of α1AT than does direct intramuscular injection of the same construct as plasmid DNA. Moreover, immunohistological labelling of muscle sections implanted with myoblasts show that the newly formed muscle fibres are those containing the human protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Partridge TA . Skeletal muscle as a target for gene therapy Gene Therapy 1994 1: 77–79

    CAS  PubMed  Google Scholar 

  2. Dahler A et al. Expression vectors encoding human growth hormone (hGH) controlled human muscle-specific promotors: prospects for regulated production hGH delivered by myoblast transfer or intravenous injection Eur J Cell Biol 1994 45: 305–310

    Google Scholar 

  3. Miller G et al. Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: modelling genetherapy for haemophilia Gene Therapy 1995 2: 736–742

    CAS  PubMed  Google Scholar 

  4. Morral N et al. Immune responses to reporter protein and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild-type and E2a-deleted vectors Hum Gene Ther 1997 8: 1275–1286

    Article  CAS  Google Scholar 

  5. Wells KE et al. Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle FEBS Lett 1997 407: 164–168

    Article  CAS  Google Scholar 

  6. Yao S, Kurachi K . Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells J Cell Sci 1993 105: 957–963

    PubMed  Google Scholar 

  7. Chamberlain JS, Jaynes JB, Hauschka SD . Regulation of creatine kinase induction in differentiating mouse myoblast Mol Cell Biol 1985 5: 484–492

    Article  CAS  Google Scholar 

  8. Levy M et al. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood GeneTherapy 1996 3: 201–211

    CAS  Google Scholar 

  9. Schneider G et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity Nat Genet 1998 18: 180–183

    Article  Google Scholar 

  10. Beauchamp JR et al. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source J Cell Biol 1999 144: 1113–1122

    Article  CAS  Google Scholar 

  11. Dai Y, Roman M, Naviaux RK, Verma IM . Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo Proc Natl Acad Sci USA 1992 89: 10892–10895

    Article  CAS  Google Scholar 

  12. Yao SN, Smith KJ, Kurachi K . Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice Gene Therapy 1994 1: 99–107

    CAS  PubMed  Google Scholar 

  13. Wang JM, Zheng H, Blaivas M, Kurachi K . Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels Blood 1997 90: 1075–1082

    CAS  PubMed  Google Scholar 

  14. Coulton GR et al. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation Neuropathol Appl Neurobiol 1988 14: 53–70

    Article  CAS  Google Scholar 

  15. McMahon J et al. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle Gene Therapy 1998 5: 1283–1290

    Article  CAS  Google Scholar 

  16. Nehls M et al. New members of the winged-helix protein family disrupted in mouse and rat nude mutations Nature 1994 372: 103–107

    Article  CAS  Google Scholar 

  17. Messina J, Gilkeson G, Pisetsky D . Stimulation of in vitro murine lymphocytes proliferation by bacterial DNA J Immunol 1991 147: 1759–1764

    CAS  PubMed  Google Scholar 

  18. Krieg A et al. CpG motifs in bacterial DNA trigger B cell activation Nature 1995 374: 546–549

    Article  CAS  Google Scholar 

  19. Manthorpe M et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice Hum Gene Ther 1993 4: 419–431

    Article  CAS  Google Scholar 

  20. Hartikka J et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle Hum Gene Ther 1996 7: 1205–1217

    Article  CAS  Google Scholar 

  21. Qin L et al. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression Hum Gene Ther 1997 8: 2019–2029

    Article  CAS  Google Scholar 

  22. Harms JS, Splitter GA . Interferon-gamma transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammilian MHC I promoter Hum Gene Ther 1995 6: 1291–1297

    Article  CAS  Google Scholar 

  23. Morgan JE et al. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines Dev Biol 1994 162: 486–498

    Article  CAS  Google Scholar 

  24. Partridge TA et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts Nature 1989 337: 176–179

    Article  CAS  Google Scholar 

  25. Wells DJ . Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle FEBS Lett 1993 332: 179–182

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr Peter Strong for the P6 antibody, Jamie Morrison for technical assistance, Kim Wells for performing the CK assay and critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bou-Gharios, G., Wells, D., Lu, Q. et al. Differential expression and secretion of alpha 1 anti-trypsin between direct DNA injection and implantation of transfected myoblast. Gene Ther 6, 1021–1029 (1999). https://doi.org/10.1038/sj.gt.3300933

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300933

Keywords

This article is cited by

Search

Quick links